Isotretinoin Treatment for Folliculitis Decalvans: A Retrospective Case-Series Study

    Berna Aksoy, Aslı Hapa, Emine Mutlu
    Studysummary In this retrospective study, oral isotretinoin monotherapy effectively achieved remission in 82% of patients with folliculitis decalvans, with those receiving ≥0.4 mg/kg/day for ≥3 months experiencing better outcomes and less frequent relapse.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 5

    1. Oral Isotretinoin as the Most Effective Treatment in Folliculitis Decalvans: A Retrospective Comparison of Different Treatment Regimens in 28 Patients Journal of the European Academy of Dermatology and Venereology · 2015
    2. Folliculitis Decalvans: A Multicenter Review of 82 Patients Journal of the European Academy of Dermatology and Venereology · 2015
    3. Retrospective Review of Folliculitis Decalvans in 23 Patients with Course and Treatment Analysis of Long-Standing Cases Journal of Cutaneous Medicine and Surgery · 2015
    4. Folliculitis Decalvans: A Rare Inflammatory Scalp Disorder Dermatologic Therapy · 2008
    5. Simultaneous Occurrence of Folliculitis Decalvans Capillitii in Identical Twins British Journal of Dermatology · 2000

    Related research 1

    1. Isotretinoin-Unresponsive Acne as a Sign of a Congenital Disorder: A Case of 21-Hydroxylase Deficiency Dermatology Reports · 2023